HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a Texas-based tissue engineering technology company focused on regrowth of the spinal disc nucleus using human dermal fibroblasts, announced today the issuance of U.S. Patent No. 9,138,460, “Methods and Compositions For Repair Of Cartilage Using An In Vivo Bioreactor.” The technology described in the patent generally involves seeding dermal fibroblasts into the nucleus of the spinal disc. The cells, when exposed to certain types of in vivo mechanical s
| < Prev | Next > |
|---|
